Haiyan J. Cai

Zhongshan Hospital Qingpu Branch
Zhongshan, 201700, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Targeting endosomal trafficking-mediated antigen escape to resensitize myeloma to CAR-T therapy.

Targeting endosomal trafficking-mediated antigen escape to resensitize myeloma to CAR-T therapy.

Journal: Journal for immunotherapy of cancer

Published: February 15, 2026

Corrigendum to "Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma" [Arch. Biochem. Biophys. 754 (2024) 109929].

Corrigendum to "Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma" [Arch. Biochem. Biophys. 754 (2024) 109929].

Journal: Archives of biochemistry and biophysics

Published: October 29, 2025

TGM2-mediated serotonylation in tumor endothelial cells promotes angiogenesis and tumor growth in colorectal cancer.

TGM2-mediated serotonylation in tumor endothelial cells promotes angiogenesis and tumor growth in colorectal cancer.

Journal: Cancer letters

Published: October 16, 2025

METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2α-PERK interaction and promoting PSMB5 translation.

METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2α-PERK interaction and promoting PSMB5 translation.

Journal: Oncogene

Published: June 23, 2025

USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγ.

USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγ.

Journal: Cell death and differentiation

Published: April 07, 2025

Discovery of novel antimyeloma agents targeting TRIP13 by molecular modeling and bioassay.

Discovery of novel antimyeloma agents targeting TRIP13 by molecular modeling and bioassay.

Journal: RSC medicinal chemistry

Published: December 18, 2024

The role of autophagy related 12 (ATG12) in the progression of hepatocellular carcinoma and its prognostic value.

The role of autophagy related 12 (ATG12) in the progression of hepatocellular carcinoma and its prognostic value.

Journal: Discover oncology

Published: September 30, 2024

Aberrant activation of adenine nucleotide translocase 3 promotes progression and chemoresistance in multiple myeloma dependent on PINK1 transport.

Aberrant activation of adenine nucleotide translocase 3 promotes progression and chemoresistance in multiple myeloma dependent on PINK1 transport.

Journal: International journal of biological sciences

Published: August 03, 2024

EZH2 inhibition induces senescence via ERK1/2 signaling pathway in multiple myeloma.

EZH2 inhibition induces senescence via ERK1/2 signaling pathway in multiple myeloma.

Journal: Acta biochimica et biophysica Sinica

Published: May 28, 2024

Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axis.

Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axis.

Journal: Journal of biomedical science

Published: May 05, 2024

Design, synthesis, and biological evaluation of novel 1-amido-2-one-4-thio-deoxypyranose as potential antitumor agents for multiple myeloma.

Design, synthesis, and biological evaluation of novel 1-amido-2-one-4-thio-deoxypyranose as potential antitumor agents for multiple myeloma.

Journal: Bioorganic & medicinal chemistry

Published: April 06, 2024

TRIP13 - a potential drug target in cancer pharmacotherapy.

TRIP13 - a potential drug target in cancer pharmacotherapy.

Journal: Bioorganic chemistry

Published: March 25, 2024

Showing 1-12 of 37

Last Updated: 09/26/2026